2C-P: Difference between revisions
>David Hedlund Removed {{toxicity}} -- not a stub any more |
>David Hedlund {{GenericPanel/warning |
||
Line 121: | Line 121: | ||
===Overdose=== | ===Overdose=== | ||
Pharmacokinetic factors that make 2C-P pretty unique and require notably caution | {{GenericPanel/warning | ||
* Steep dose-response curve: As little as a few extra milligrams separating a manageable dose and an overdose.<ref name="Erowid" /> Users who wish to take high doses of this compound are advised to titrate upward slowly, use reliable milligram scales to measure doses, and avoid non-oral routes of administration such as insufflation or injection. | | title=Pharmacokinetic factors that make 2C-P pretty unique and require notably caution | ||
| content=* Steep dose-response curve: As little as a few extra milligrams separating a manageable dose and an overdose.<ref name="Erowid" /> Users who wish to take high doses of this compound are advised to titrate upward slowly, use reliable milligram scales to measure doses, and avoid non-oral routes of administration such as insufflation or injection. | |||
* Very slow onset: The peak effects reportedly do not occur for 1 to 3 hours.<ref name="Erowid">{{Citation | title=Erowid Online Books : “PIHKAL” - #36 2C-P | url=https://www.erowid.org/library/books_online/pihkal/pihkal036.shtml}}</ref> Thus it's advised to wait for at least 3 hours before re-dosing is considered. | * Very slow onset: The peak effects reportedly do not occur for 1 to 3 hours.<ref name="Erowid">{{Citation | title=Erowid Online Books : “PIHKAL” - #36 2C-P | url=https://www.erowid.org/library/books_online/pihkal/pihkal036.shtml}}</ref> Thus it's advised to wait for at least 3 hours before re-dosing is considered. | ||
* Long half-life: The anecdotal estimated elimination half-life is 19 hours.<ref>https://pubmed.ncbi.nlm.nih.gov/28130544/</ref> | * Long half-life: The anecdotal estimated elimination half-life is 19 hours.<ref>https://pubmed.ncbi.nlm.nih.gov/28130544/</ref> | ||
}}<noinclude>[[Category:Panels]]</noinclude> | |||
The LD<sub>50</sub> of 2C-P has not been established. However, it is believed that 2C-P is likely to have a smaller therapeutic window compared to other 2C's, meaning a lethal dose may be achieved more easily. | The LD<sub>50</sub> of 2C-P has not been established. However, it is believed that 2C-P is likely to have a smaller therapeutic window compared to other 2C's, meaning a lethal dose may be achieved more easily. |